Printer Friendly

Browse Sunitinib topic

Articles

1-136 out of 136 article(s)
Title Author Type Date Words
Bristol-Myers, Exelixis announce results from Phase 3 CheckMate -9ER trial. Financial report Sep 20, 2020 377
Ipsen announces results from Phase III CheckMate -9ER trial. Sep 20, 2020 409
Deciphera presents nine month follow-up data from INVICTUS study at ESMO. Clinical report Sep 18, 2020 400
Bristol-Myers reports four-year data of Opdivo combination in RCC. Sep 17, 2020 322
Clinicopathologic Features of Gastroenteropancreatic Neuroendocrine Tumors: A Single-center Experience. Telli, Tugba Akin; Esin, Ece; Yalcin, Suayib Sep 1, 2020 4609
Zai Lab receives China NMPA acceptance of NDA submission of ripretinib. Jul 20, 2020 349
Deciphera presents new data from Phase 3 INVICTUS study of Qinlock. Jul 2, 2020 355
A pictorial review on clinicopathologic and radiologic features of duodenal gastrointestinal stromal tumors. Jung, Haerang; Lee, Sang Min; Kim, Young Chul; Byun, Jieun; Kwon, Mi Jung Jul 1, 2020 2414
Health Canada's Authorizes Qinlock for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor. Jun 23, 2020 223
Deciphera announces Health Canada authorizes sale of Qinlock. Jun 22, 2020 268
Elucidation of the Molecular Mechanisms Underlying Sorafenib Induced Hepatotoxicity. AlAsmari, Abdullah F.; Ali, Nemat; AlAsmari, Fawaz; AlAnazi, Wael A.; Alqahtani, Faleh; Alharbi, Met May 31, 2020 5571
US FDA approves Qinlock tablets for treatment of advanced gastrointestinal stromal tumour. May 18, 2020 163
US FDA approves Qinlock tablets for treatment of advanced gastrointestinal stromal tumour. May 18, 2020 159
The FDA approves Qinlock (ripretinib) tablets for fourth line treatment of advanced gastrointestinal stromal tumours. May 18, 2020 256
The FDA approves Qinlock (ripretinib) tablets for fourth line treatment of advanced gastrointestinal stromal tumours. May 18, 2020 260
FDA approves Deciphera's fourth-line treatment of advanced GIST. May 15, 2020 207
Intramuscular metastasis of renal cell carcinoma: A rare occurrence, diagnosed on fine-needle aspiration cytology. Agnihotri, Mona; Kothari, Kanchan; Naik, Leena Letter to the editor May 1, 2020 886
Deep and Prolonged Response to Aurora A Kinase Inhibitor and Subsequently to Nivolumab in MYCL1-Driven Small-Cell Lung Cancer: Case Report and Literature Review. Kolla, Bhaskar C.; Racila, Emilian; Patel, Manish R. Apr 30, 2020 3663
Combination Use of Tegafur and Apatinib as First-Line Therapy in Treatment of Advanced Gastric Cancer: A Single-Blinded Randomized Study. Li, Chaofeng; Tang, Tao; Wang, Wenyue Clinical report Apr 30, 2020 4156
Bristol-Myers, Exelixis: CheckMate-9ER met primary endpoint of PFS. Apr 20, 2020 178
Bristol Myers Squibb, Exelixis Tout Positive Topline Results from Pivotal Phase 3 CheckMate -9ER Trial Evaluating Opdivo in Combination with Cabometyx in Previously Untreated Advanced Renal Cell Carcinoma. Apr 20, 2020 316
Objective Clinical and Radiological Response under Sunitinib in a Case of Thigh Hidradenocarcinoma. Korbi, S.; Rachdi, H.; Benna, H. El; Mejri, N.; Berrazaga, Y.; Daoud, N.; Labidi, S.; Boussen, H. Mar 31, 2020 1383
Germ Cell Tumor with Bronchial Fistula. Leguia, Maria Katherinne Florez; Calvete, Paula Camila Riveros; Ojeda, Paulina; Bayona, Jorge Albert Mar 31, 2020 1467
Opdivo Plus Yervoy Demonstrates Continued Survival Benefit at 42-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma. Feb 19, 2020 647
Rare intrathoracic metastases of renal cell carcinoma. Bolat, Mustafa Suat; Celik, Burcin; Cinar, Huseyin Ulas Jan 1, 2020 1480
Cell Adhesion-Related Molecules Play a Key Role in Renal Cancer Progression by Multinetwork Analysis. Wang, Anbang; Chen, Ming; Wang, Hui; Huang, Jinming; Bao, Yi; Gan, Xinxin; Liu, Bing; Lu, Xin; Wang, Dec 31, 2019 4803
Global Gastric Cancer Drugs Market Segmentation By Type, Historic and Forecast, 2020 By Radiant Insights, Inc. Dec 20, 2019 679
Gastric Cancer Drugs Market To Grow At A CAGR Of 11.1% During 2018-2022. Dec 20, 2019 745
Deciphera Pharmaceuticals Submits New Drug Application to US FDA for Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors. Dec 17, 2019 700
The importance of genetic study and long-term management in patients with bilateral pheochromocytomas. Bellarbi, Dhiya Eddine; Chentli, Farida Dec 1, 2019 2262
Insulin-Like Growth Factor Binding Protein 5--A Probable Target of Kidney Renal Papillary Renal Cell Carcinoma. Wang, Shuqiang; Hong, Quan; Geng, Xiaodong; Chi, Kun; Cai, Guangyan; Wu, Di Nov 30, 2019 5394
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1. Badalamenti, Giuseppe; Barraco, Nadia; Incorvaia, Lorena; Galvano, Antonio; Fanale, Daniele; Cabibi, Nov 30, 2019 4725
European Commission grants approval to Pfizer and Merck's Bavencio in combination with axitinib. Oct 30, 2019 226
European Commission grants approval to Pfizer and Merck's Bavencio in combination with axitinib. Oct 30, 2019 222
Pheochromocytoma Pipeline Insights, 2019 Report. Report Oct 22, 2019 875
Contralateral Testicular Metastasis of Renal Cell Carcinoma: A Case Report. Kolukcu, Engin; Kilic, Sahin; Parlaktas, Bekir Suha; Deresoy, Faik Alev; Atilgan, Dogan; Gumusay, Oz Letter to the editor Oct 1, 2019 1470
The role of KDR in intrauterine adhesions may involve the TGF-[beta]1/Smads signaling pathway. Chen, Jian Xia; Yi, Xi Juan; Gu, Pei Ling; Gao, Shan Xia Report Oct 1, 2019 5361
European Medicines Agency's committee provides positive opinion recommending approval of BAVENCIO. Sep 24, 2019 166
European Medicines Agency's committee provides positive opinion recommending approval of BAVENCIO. Sep 24, 2019 194
European Medicines Agency's committee provides positive opinion recommending approval of BAVENCIO. Sep 24, 2019 162
Graybug Vision starts phase 2a study with GB-102. Sep 20, 2019 177
Graybug Vision starts phase 2a study with GB-102. Sep 20, 2019 173
Pfizer, EMD Serono announce CHMP opinion recommending approval of Bavencio. Sep 20, 2019 121
Soft Tissue Sarcoma Market Size 2019, Global Industry Overview, Share, Growth, Competitive Landscape, Key Players, Regional Forecast to 2023. Industry overview Sep 17, 2019 1047
Gastric Neuroendocrine Tumors Pipeline Insight 2019. Disease/Disorder overview Sep 16, 2019 1135
Global and Chinese Market Sunitinib Market Insights, 2014-2019 & 2019-2024 by Manufacturers, Product Type, Application, and Technology. Sep 11, 2019 740
Neuroendocrine Cancer Market 2019: Global Key Players, Trends, Share, Industry Size, Segmentation, Opportunities, Forecast To 2026. Sep 4, 2019 656
Merck's Keytruda combination with Inlyta approved in Europe for carcinoma. Sep 4, 2019 114
Ultrasound-Proven Severe Synovitis Induced by PD-1 Inhibitor Therapy in a Patient Predisposed to Seronegative Inflammatory Arthritis. Kawashiri, Shin-Ya; Iwamoto, Naoki; Ohba, Kojiro; Kawakami, Atsushi Aug 31, 2019 1384
Unusual Suspect: A Case Report of Tubulocystic Renal Cell Carcinoma with Features of Cystic Renal Oncocytoma. McFadden, Jacob D.; Sesterhenn, Isabell A.; Kern, Sean Q. Aug 31, 2019 2292
The Prognostic Significance of Protein Expression of CASZ1 in Clear Cell Renal Cell Carcinoma. Kim, Bohyun; Jung, Minsun; Moon, Kyung Chul Aug 31, 2019 4433
Vimentin Overexpressions Induced by Cell Hypoxia Promote Vasculogenic Mimicry by Renal Cell Carcinoma Cells. Lin, Hao; Hong, Yingkai; Huang, Bin; Liu, Xincheng; Zheng, Junhong; Qiu, Shaopeng Aug 31, 2019 5232
Immunicum reports positive phase II MERECA topline results from MERECA clinical trial. Clinical report Aug 30, 2019 273
Immunicum reports positive phase II MERECA topline results from MERECA clinical trial. Clinical report Aug 30, 2019 274
Immunicum reports positive phase II MERECA topline results from MERECA clinical trial. Clinical report Aug 30, 2019 269
Neuroendocrine Tumor Treatment Market to Surpass US$ 2.9 Billion by 2025, Underpinned by Increasing Incidence of GI and Lung Neuroendocrine Tumors - Coherent Market Insights. Aug 26, 2019 932
Global Soft Tissue Sarcoma Market to Exhibit 8.2% CAGR by 2023, Increase Prevalence Rate Fueling the Demand for Soft Tissue Sarcoma Treatment. Aug 21, 2019 1056
Deciphera Pharmaceuticals Reports Positive Updated Phase 1 Data for Ripretinib in Gastrointestinal Stromal Tumors. Aug 14, 2019 684
Deciphera Soars On Positive Readouts For Gastrointestinal Tumor Drug. Aug 13, 2019 504
Deciphera announces top-line results from Phase 3 INVICTUS study. Clinical report Aug 13, 2019 395
Corrigendum to "Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib". Gorini, Stefania; de Angelis, Antonella; Berrino, Liberato; Malara, Natalia; Rosano, Giuseppe; Ferra Correction notice Jul 31, 2019 192
Multiple Roles of Exosomal Long Noncoding RNAs in Cancers. Zhao, Wenyuan; Liu, Yuanqi; Zhang, Chunfang; Duan, Chaojun Jul 31, 2019 8159
Merck (MRK). Jul 26, 2019 3393
Sunitinib Malate Market Research Report Overview, Scope, Top Manufacturers, and Forecast to 2025. Report Jul 23, 2019 892
Merck (MRK). Jul 19, 2019 3337
Merck (MRK). Jul 10, 2019 3332
Merck (MRK). Jul 5, 2019 3310
Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC). Sheng, Iris Y.; Kruse, Megan; Leininger, Kathryn M.; Ornstein, Moshe C. Report Jun 30, 2019 882
Merck (MRK). Jun 26, 2019 3259
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES)--CASE REPORT & REVIEW OF LITERATURE. Raman, Sarojini; Behera, Chinmay Kumar; Senapati, Urmila Jun 17, 2019 2771
Deciphera Pharmaceuticals, Zai Lab Ink Exclusive License Agreement for Ripretinib in Greater China. Jun 13, 2019 539
Merck (MRK). Jun 13, 2019 3280
Deciphera, Zai Lab announce ripretinib license agreement in Greater China. Jun 11, 2019 169
Deciphera, Zai Lab announce exclusive license agreement for ripretinib. Jun 11, 2019 170
Merck (MRK). Jun 4, 2019 3282
QU student investigates anti-cancer drugs causing cardiotoxicity. Jun 2, 2019 363
A rare case of Wild-Type GIST of descending colon with GANT characteristics. Kalliouris, Dimitrios N.; Nikou, Efstathios; Zaravinos, Spiridon; Manesis, Konstantinos; Oikonomou, Letter to the editor Jun 1, 2019 1426
Nuclear Medicine Applications in Diagnosis of Urological Tumors. Araz, Mine; Urun, Yuksel Jun 1, 2019 8026
A rare case of Wild-Type GIST of descending colon with GANT characteristics. Kalliouris, Dimitrios N.; Nikou, Efstathios; Zaravinos, Spiridon; Manesis, Konstantinos; Oikonomou, Jun 1, 2019 1485
Somatostatinoma Presented as Double-Duct Sign. Zakaria, Ali; Hammad, Nour; Vakhariya, Cynthia; Raphael, Michael May 31, 2019 2557
Merck (MRK). May 29, 2019 3279
Merck (MRK). May 22, 2019 3281
Merck (MRK). May 15, 2019 3283
FDA approves Pfizer's Bavencio+Inlyta for advanced renal cell carcinoma. May 14, 2019 146
Merck (MRK). May 8, 2019 3284
Merck (MRK). May 2, 2019 3281
Late metachronous isolated pancreatic metastasis from renal cell carcinoma mimicking a pancreatic neuroendocrine tumor. Chon, Hyung Ku; Choi, Ha Letter to the editor May 1, 2019 930
Influence of Interleukin-8 and Neutrophil Extracellular Trap (NET) Formation in the Tumor Microenvironment: Is There a Pathogenic Role? Gonzalez-Aparicio, Manuela; Alfaro, Carlos Apr 30, 2019 5598
CDK5RAP3 Participates in Autophagy Regulation and Is Downregulated in Renal Cancer. Li, Jun; Hu, Xinyi; Su, Ming; Shen, Hongliang; Qiu, Wei; Tian, Ye Apr 30, 2019 3686
Medication-Related Osteonecrosis of the Jaws: Two Center Retrospective Cohort Studies. Petrovic, Milan; Jelovac, Drago B.; Antic, Svetlana; Antunovic, Marija; Lukic, Nikola; Sabani, Melvi Clinical report Apr 30, 2019 5102
US Food and Drug Administration grants approval to Merck's Keytruda in combination with Inlyta. Apr 24, 2019 207
US Food and Drug Administration grants approval to Merck's Keytruda in combination with Inlyta. Apr 24, 2019 203
FDA Approves Merck's Keytruda in Combination with Inlyta as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma. Apr 23, 2019 160
Merck: FDA approves KEYTRUDA in combination with Inlyta. Apr 22, 2019 193
Aptose Biosciences presents preclinical data on CG-806, APTO-253 at AACR. Apr 1, 2019 283
Acute Right Lower Abdomen in a Patient with a History of Gastrointestinal Stromal Tumor. Bandyopadhyay, Dabanjan; Bonatti, Hugo J.R. Mar 31, 2019 1780
CAPTEM in Metastatic Well-Differentiated Intermediate to High Grade Neuroendocrine Tumors: A Single Centre Experience. Sahu, Arvind; Jefford, Michael; Lai-Kwon, Julia; Thai, Alesha; Hicks, Rodney J.; Michael, Michael Mar 31, 2019 4059
ORIC Pharmaceuticals names new senior vice president of Clinical Development. Mar 5, 2019 265
ORIC Pharmaceuticals names new senior vice president of Clinical Development. Mar 5, 2019 261
Anticancer activities and cell death mechanisms of 1H-indole-2,3-dione 3-[N-(4 sulfamoylphenyl) thiosemicarbazone] derivatives. Cetin, Idil; Elma, Pinar Eraslan; Topcul, Mehmet; Karali, Nilgun Report Dec 1, 2018 2634
ASCO: Sunitinib Alone Noninferior in Metastatic Renal Cell Cancer; Sunitinib alone noninferior to nephrectomy plus sunitinib with respect to overall survival. Jun 4, 2018 274
Nivolumab Plus Ipilimumab Tops Sunitinib for Advanced Renal CA; Overall survival, objective response higher than sunitinib for untreated clear-cell advanced RCC. Mar 23, 2018 265
Risk Factors for Fatal Pulmonary Hemorrhage following Concurrent Chemoradiotherapy in Stage 3B/C Squamous-Cell Lung Carcinoma Patients. Topkan, Erkan; Selek, Ugur; Ozdemir, Yurday; Besen, Ali A.; Guler, Ozan C.; Yildirim, Berna A.; Mert Jan 1, 2018 5650
Combined Volumetric and Density Analyses of Contrast-Enhanced CT Imaging to Assess Drug Therapy Response in Gastroenteropancreatic Neuroendocrine Diffuse Liver Metastasis. Wang, Yi; Huang, Kun; Chen, Jie; Luo, Yanji; Zhang, Yu; Jia, Yingmei; Xu, Ling; Chen, Minhu; Huang, Jan 1, 2018 5839
A Case of Pneumothorax after Treatment with Lenvatinib for Anaplastic Thyroid Cancer with Lung Metastasis. Yamazaki, Haruhiko; Iwasaki, Hiroyuki; Yamashita, Toshinari; Yoshida, Tatsuya; Suganuma, Nobuyasu; Y Jan 1, 2018 1657
Genomic Subtypes of GISTs for Stratifying Patient Response to Sunitinib following Imatinib Resistance: A Pooled Analysis and Systematic Review. Tan, Siyuan; Chen, Ping; Ji, Jiafu; Guo, Shanshan; Yu, Dapeng; Asakawa, Tetsuya; Zhou, Yu; Abe, Masa Jan 1, 2018 5643
A Rare Case of Metastasis to the Thyroid Gland from Renal Clear Cell Carcinoma 11 Years after Nephrectomy and Concurrent Primary Esophageal Carcinoma. Khan, Mohammad Saud; Iyer, Veena Balakrishnan; Varshney, Neha Jan 1, 2018 1882
Oral Capecitabine Achieves Response in Metastatic Eccrine Carcinoma. Larson, Kristian; Babiker, Hani M.; Kovoor, Andrew; Liau, Joy; Eldersveld, Jordan; Elquza, Emad Jan 1, 2018 2408
Metastatic Renal Cell Carcinoma Presenting as Prolonged Pyrexia and Stauffer's Syndrome: Can a Routine Ultrasound Scan Fail to Detect a Renal Cell Carcinoma? Fonseka, C.L.; Kariyawasam, A.G.T.A.; Singhapura, S.A.G.L.; Silva, C.M. de; Kanakkahewa, T.E.; Senar Jan 1, 2018 2145
Vaginal Bleeding as Initial Presentation of an Aggressive Renal Cell Carcinoma: A Case Report and Review of the Literature. Jimenez, Antonio R.; Rolon, Maria del Mar Rivera; Eyzaguirre, Eduardo; Clement, Cecilia Jan 1, 2018 1706
Clostridium perfringens Septicemia and a Bleeding Ulcer of a Jejunal Interposition: A Case Report and Short Review of the Literature. Wild, W.; Bormann, F.; Sweiti, H.; Tamimi, N.; Pichulek, D.; Divo, M.; Dorr, P.; Schwarzbach, M. Jan 1, 2018 2407
Adrenal Hemangioma: A Case of Retroperitoneal Tumor. Iwamoto, Genta; Shimokihara, Kota; Kawahara, Takashi; Takamoto, Daiji; Yao, Masahiro; Teranishi, Jun Jan 1, 2018 1589
Thrombotic Thrombocytopenic Purpura due to Checkpoint Inhibitors. Youssef, Alexey; Kasso, Nawara; Torloni, Antonio Sergio; Stanek, Michael; Dragovich, Tomislav; Gimbe Jan 1, 2018 2098
Anti-Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms. Zheng, Weilin; Cao, Lixing; Xu, Zheng; Ma, Yuanyuan; Liang, Xuefang Report Jan 1, 2018 18431
Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib. Gorini, Stefania; De Angelis, Antonella; Berrino, Liberato; Malara, Natalia; Rosano, Giuseppe; Ferra Jan 1, 2018 12089
Extraskeletal Myxoid Chondrosarcoma: A Comparative Study of Imaging and Pathology. Zhang, Ling; Wang, Ruoning; Xu, Rong; Qin, Genggeng; Yang, Lei Report Jan 1, 2018 4458
Influences of Anlotinib on Cytochrome P450 Enzymes in Rats Using a Cocktail Method. Sun, Wei; Wang, Zhe; Chen, Ruimin; Huang, Chengke; Sun, Rui; Hu, Xiaoxia; Li, Wanshu; Chen, Ruijie Jan 1, 2018 3962
First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience. Lalani, Aly-Khan A.; Li, Haocheng; Heng, Daniel Y.C.; Wood, Lori; Kalirai, Austin; Bjarnason, Georg Report Mar 1, 2017 4489
Reversible posterior leukoencephalopathy syndrome developing after restart of sunitinib therapy for metastatic renal cell carcinoma. Fukui, Shinji; Toyoshima, Yuta; Inoue, Takeshi; Kagebayashi, Yoriaki; Samma, Shoji Case study Jan 1, 2016 2256
Cancer drug's effectiveness inflated in animal studies. Saey, Tina Hesman Brief article Nov 14, 2015 147
Analyses of Potential Predictive Markers and Response to Targeted Therapy in Patients with Advanced Clear-cell Renal Cell Carcinoma. Song, Yan; Huang, Jing; Shan, Ling; Zhang, Hong-Tu Report Aug 5, 2015 4317
Metastatic renal cell cancer: summary from ASCO 2015. Conference notes Aug 1, 2015 2447
More than 10 years survival with sequential therapy in a patient with advanced renal cell carcinoma: a case report. Yuan, J.L.; Wang, F.L.; Yi, X.M.; Qin, W.J.; Wu, G.J.; Huan, Y.; Yang, L.J.; Zhang, G.; Yu, L.; Zhan Case study Jan 1, 2015 3207
BLOMARCADORES EN LA DETECCION TEMPRANA DE CARDIOTOXICIDAD INDUCIDA POR QUIMIOTERAPIA; ESTADO ACTUAL. Jimenez Cotes, Evert Armando; Meyer Martinez, Wendy Sofia; Gallego Gonzalez, Daniel Jan 1, 2015 5822
Metachronous duodenal metastasis from renal cell carcinoma. Hu, Jeming; Wu, Sheng-Tang; Lin, Yu-Chieh; Chang, Hao-Ming Report Jul 1, 2014 2113
Sunitinib-induced hand-foot syndrome in a Kashmiri male. Mir, Mohammad H.; Rather, Parvaiz A.; Bagdadi, Farhana Jun 30, 2014 1818
What's new in renal cell cancer research? Highlights of GU-ASCO 2014. Kapoor, Anil Conference notes Mar 1, 2014 1701
Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib. Iacovelli, Roberto; Cartenì, Giacomo; Milella, Michele; Berardi, Rossana; Di Lorenzo, Giusep Report Mar 1, 2014 3023
Sunitinib induced thrombotic thrombocytopenic purpura in addition to severe hypothyroidism: a case report and review of the literature. Dika, Imane El; Mukherji, Deborah; Temraz, Sally; Assi, Rita; Shamseddine, Ali Jan 1, 2014 2108
Dose escalation of second-line sunitinib results in rapid partial remission of multiple hepatic metastases. Guevremont, Catherine; Mija, Florin I.; Isbarn, Hendrik; Jeldres, Claudio; Lughezzani, Giovanni; Sun Case study Dec 1, 2009 1295
Pfizer Inc.'s (New York) Sutent delayed the worsening of the type of pancreatic cancer that afflicted Apple Inc. (Cupertino CA) Chief Executive Steve Jobs by more than five months longer than a placebo, according to data from a clinical trial. Brief article Jun 29, 2009 289
Pfizer Inc. Brief article Apr 6, 2009 221
New thyroid cancer drug class making waves. Jancin, Bruce Dec 1, 2008 904
Watch side effects when using TKIs for thyroid cancer. Jancin, Bruce Dec 1, 2008 648
Sunitinib superior to interferon-[alpha] for advanced renal cell carcinoma. Lowry, Fran Oct 15, 2006 412
New antiangiogenesis agents fight lung cancer. MacNeil, Jane Salodof Aug 1, 2006 947

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters